Bone agent linked to problems in neck surgeries

Courtesy Headlines from the Associated Press  Tue, 06/30/2009 - 14:02

CHICAGO (AP) -- A bone growth agent used in thousands of spinal fusion surgeries for neck pain has been linked to complications and higher cost, according to the first nationwide study of the product.

Safety questions arose last year about the protein product, BMP, when used in fusion surgeries in the neck region, a use not approved by federal regulators....

Tags:

 

More related items

Spine Surgeons React to BMP-2 Cancer Data
CHICAGO (MedPage Today) -- Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years...

BMP-2 Researchers Minimized Cancer Finding
(MedPage Today) -- This latest report from an ongoing Journal Sentinel/MedPage Today investigation details the story behind the 2009 publication of a study that was designed as a key part of...

Spinal Fusion Patients Immobilized by Pain
(MedPage Today) -- An ongoing Milwaukee Journal Sentinel/MedPage Today investigation into a bone morphogenetic protein-2 device marketed as Infuse has uncovered a number of concerns about the...

Burt's Bees Free Head to Toe Starter Kit

Lobe Wonder Ear Support Patches For Earrings,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com